Literature DB >> 23384558

The High Mobility Group A proteins contribute to thyroid cell transformation by regulating miR-603 and miR-10b expression.

Paula Mussnich1, Daniela D'Angelo, Vincenza Leone, Carlo Maria Croce, Alfredo Fusco.   

Abstract

The overexpression of the HMGA1 proteins is a feature of human malignant neoplasias and has a causal role in cell transformation. The aim of our study has been to investigate the microRNAs (miRNAs or miRs) regulated by the HMGA1 proteins in the process of cell transformation analyzing the miRNA expression profile of v-ras-Ki oncogene-transformed thyroid cells expressing or not HMGA1 proteins. We demonstrate that, among the miRNAs regulated by cell transformation, there are miR-10b, miR-21, miR-125b, miR-221 and miR-222 that are positively and miR-34a and miR-603 that are negatively regulated by HMGA1 expression. Then, we focused our attention on the miR-10b and miR-603 whose expression was dependent on the presence of HMGA1 also in other cell systems. We found that miR-10b is able to target the PTEN gene, whereas miR-603 targets the CCND1 and CCND2 genes coding for the cyclin D1 and cyclin D2 proteins, respectively. Moreover, functional studies showed that miR-10b and miR-603 regulate positively and negatively, respectively, cell proliferation and migration suggesting a role of their dysregulation in thyroid cell transformation.
Copyright © 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23384558      PMCID: PMC5528467          DOI: 10.1016/j.molonc.2013.01.002

Source DB:  PubMed          Journal:  Mol Oncol        ISSN: 1574-7891            Impact factor:   6.603


  58 in total

Review 1.  How microRNAs control cell division, differentiation and death.

Authors:  Eric A Miska
Journal:  Curr Opin Genet Dev       Date:  2005-10       Impact factor: 5.578

2.  Epigenetic regulation of microRNA-10b and targeting of oncogenic MAPRE1 in gastric cancer.

Authors:  Kwoneel Kim; Han-Chul Lee; Jong-Lyul Park; Mirang Kim; Seon-Young Kim; Seung-Moo Noh; Kyu-Sang Song; Jin Cheon Kim; Yong Sung Kim
Journal:  Epigenetics       Date:  2011-06-01       Impact factor: 4.528

3.  Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome.

Authors:  D Liaw; D J Marsh; J Li; P L Dahia; S I Wang; Z Zheng; S Bose; K M Call; H C Tsou; M Peacocke; C Eng; R Parsons
Journal:  Nat Genet       Date:  1997-05       Impact factor: 38.330

4.  Identification of a New Pathway for Tumor Progression: MicroRNA-181b Up-Regulation and CBX7 Down-Regulation by HMGA1 Protein.

Authors:  Gelsomina Mansueto; Floriana Forzati; Angelo Ferraro; Pierlorenzo Pallante; Mimma Bianco; Francesco Esposito; Antonino Iaccarino; Giancarlo Troncone; Alfredo Fusco
Journal:  Genes Cancer       Date:  2010-03

5.  Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis.

Authors:  P Sicinski; J L Donaher; Y Geng; S B Parker; H Gardner; M Y Park; R L Robker; J S Richards; L K McGinnis; J D Biggers; J J Eppig; R T Bronson; S J Elledge; R A Weinberg
Journal:  Nature       Date:  1996-12-05       Impact factor: 49.962

6.  PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer.

Authors:  J Li; C Yen; D Liaw; K Podsypanina; S Bose; S I Wang; J Puc; C Miliaresis; L Rodgers; R McCombie; S H Bigner; B C Giovanella; M Ittmann; B Tycko; H Hibshoosh; M H Wigler; R Parsons
Journal:  Science       Date:  1997-03-28       Impact factor: 47.728

Review 7.  The high mobility group A1 gene: transforming inflammatory signals into cancer?

Authors:  Linda M S Resar
Journal:  Cancer Res       Date:  2010-01-12       Impact factor: 12.701

8.  Overexpression of the HMGA2 gene in transgenic mice leads to the onset of pituitary adenomas.

Authors:  Monica Fedele; Sabrina Battista; Lawrence Kenyon; Gustavo Baldassarre; Vincenzo Fidanza; Andres J P Klein-Szanto; A F Parlow; Rosa Visone; Giovanna M Pierantoni; Eric Outwater; Massimo Santoro; Carlo M Croce; Alfredo Fusco
Journal:  Oncogene       Date:  2002-05-09       Impact factor: 9.867

9.  Altered microRNA expression profile in human pituitary GH adenomas: down-regulation of miRNA targeting HMGA1, HMGA2, and E2F1.

Authors:  Daniela D'Angelo; Dario Palmieri; Paula Mussnich; Magali Roche; Anne Wierinckx; Gerald Raverot; Monica Fedele; Carlo Maria Croce; Jacqueline Trouillas; Alfredo Fusco
Journal:  J Clin Endocrinol Metab       Date:  2012-05-07       Impact factor: 5.958

10.  A microRNA expression signature of human solid tumors defines cancer gene targets.

Authors:  Stefano Volinia; George A Calin; Chang-Gong Liu; Stefan Ambs; Amelia Cimmino; Fabio Petrocca; Rosa Visone; Marilena Iorio; Claudia Roldo; Manuela Ferracin; Robyn L Prueitt; Nozumu Yanaihara; Giovanni Lanza; Aldo Scarpa; Andrea Vecchione; Massimo Negrini; Curtis C Harris; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-03       Impact factor: 11.205

View more
  23 in total

Review 1.  The high mobility group A1 molecular switch: turning on cancer - can we turn it off?

Authors:  Tait H Huso; Linda M S Resar
Journal:  Expert Opin Ther Targets       Date:  2014-03-31       Impact factor: 6.902

2.  Hitting the bull's eye: targeting HMGA1 in cancer stem cells.

Authors:  Breann L Yanagisawa; Linda M S Resar
Journal:  Expert Rev Anticancer Ther       Date:  2014-01       Impact factor: 4.512

Review 3.  Critical role of HMGA proteins in cancer cell chemoresistance.

Authors:  Daniela D'Angelo; Paula Mussnich; Claudio Arra; Sabrina Battista; Alfredo Fusco
Journal:  J Mol Med (Berl)       Date:  2017-03-14       Impact factor: 4.599

4.  Over-expression of miR-10b in NPC patients: correlation with LMP1 and Twist1.

Authors:  Nesrine Allaya; Abdelmajid Khabir; Tahia Sallemi-Boudawara; Noura Sellami; Jamel Daoud; Abdelmonem Ghorbel; Mounir Frikha; Ali Gargouri; Raja Mokdad-Gargouri; Wajdi Ayadi
Journal:  Tumour Biol       Date:  2015-01-20

5.  Downregulation of DNMT3A Attenuates the Warburg Effect, Proliferation, and Invasion via Promoting the Inhibition of miR-603 on HK2 in Ovarian Cancer.

Authors:  Jiaojiao Lu; Shuai Zhen; Xiaoqian Tuo; Shixue Chang; Xiling Yang; Yuanyuan Zhou; Wei Chen; Le Zhao; Xu Li
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec

6.  The High Mobility Group A proteins contribute to thyroid cell transformation by regulating miR-603 and miR-10b expression.

Authors:  Paula Mussnich; Daniela D'Angelo; Vincenza Leone; Carlo Maria Croce; Alfredo Fusco
Journal:  Mol Oncol       Date:  2013-01-17       Impact factor: 6.603

7.  Aberrant microRNA expression likely controls RAS oncogene activation during malignant transformation of human prostate epithelial and stem cells by arsenic.

Authors:  Ntube N O Ngalame; Erik J Tokar; Rachel J Person; Yuanyuan Xu; Michael P Waalkes
Journal:  Toxicol Sci       Date:  2014-01-15       Impact factor: 4.849

8.  Ablation of miR-10b Suppresses Oncogene-Induced Mammary Tumorigenesis and Metastasis and Reactivates Tumor-Suppressive Pathways.

Authors:  Jongchan Kim; Ashley N Siverly; Dahu Chen; Min Wang; Yuan Yuan; Yumeng Wang; Hyemin Lee; Jinsong Zhang; William J Muller; Han Liang; Boyi Gan; Xianbin Yang; Yutong Sun; M James You; Li Ma
Journal:  Cancer Res       Date:  2016-08-28       Impact factor: 12.701

9.  MicroRNA-10b inhibition reduces E2F1-mediated transcription and miR-15/16 activity in glioblastoma.

Authors:  Nadiya M Teplyuk; Erik J Uhlmann; Andus Hon-Kit Wong; Priya Karmali; Meenakshi Basu; Galina Gabriely; Anant Jain; Yang Wang; E Antonio Chiocca; Robert Stephens; Eric Marcusson; Ming Yi; Anna M Krichevsky
Journal:  Oncotarget       Date:  2015-02-28

10.  miR-198 Represses the Proliferation of HaCaT Cells by Targeting Cyclin D2.

Authors:  Jian Wang; Guorong Dan; Tao Shangguan; Han Hao; Ran Tang; Kaige Peng; Jiqing Zhao; Huiqin Sun; Zhongmin Zou
Journal:  Int J Mol Sci       Date:  2015-07-27       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.